New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...

The new deal means that GSK will collaborate with BioVersys on the development of the orally active drug – called alpibectir (BVL-GSK098) – beyond a current phase 2a trial in pulmonary TB ...

Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

Jan. 15, 2025 — Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in ...